# Effects of a Dietary Supplement Containing L-Arabinose and Trivalent Patented Food-source of Chromium on Blood Glucose and Insulin

> **NCT01107431** · NA · COMPLETED · sponsor: **Integrative Health Technologies, Inc.** · enrollment: 70 (actual)

## Conditions studied

- Pre-diabetes

## Interventions

- **DIETARY_SUPPLEMENT:** L-Arabinose and Chromium
- **DIETARY_SUPPLEMENT:** Sucrose without dietary Supplement

## Key facts

- **NCT ID:** NCT01107431
- **Lead sponsor:** Integrative Health Technologies, Inc.
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2011-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01107431

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01107431, "Effects of a Dietary Supplement Containing L-Arabinose and Trivalent Patented Food-source of Chromium on Blood Glucose and Insulin". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01107431. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*